Stevens Capital Management LP Sells 5,807 Shares of Universal Health Services, Inc. (NYSE:UHS)

Stevens Capital Management LP lessened its position in Universal Health Services, Inc. (NYSE:UHS - Free Report) by 62.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,422 shares of the health services provider's stock after selling 5,807 shares during the period. Stevens Capital Management LP's holdings in Universal Health Services were worth $522,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of UHS. Czech National Bank increased its stake in Universal Health Services by 45.8% during the 3rd quarter. Czech National Bank now owns 10,861 shares of the health services provider's stock worth $1,366,000 after acquiring an additional 3,411 shares during the period. Asset Management One Co. Ltd. lifted its holdings in Universal Health Services by 10.8% during the 3rd quarter. Asset Management One Co. Ltd. now owns 28,456 shares of the health services provider's stock worth $3,578,000 after buying an additional 2,770 shares during the period. Handelsbanken Fonder AB raised its position in shares of Universal Health Services by 13.4% in the 3rd quarter. Handelsbanken Fonder AB now owns 9,300 shares of the health services provider's stock worth $1,169,000 after acquiring an additional 1,100 shares in the last quarter. Linden Thomas Advisory Services LLC increased its position in Universal Health Services by 2.1% in the 3rd quarter. Linden Thomas Advisory Services LLC now owns 5,816 shares of the health services provider's stock valued at $731,000 after buying an additional 122 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. increased its position in Universal Health Services by 1.5% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 33,440 shares of the health services provider's stock valued at $4,204,000 after buying an additional 482 shares in the last quarter. Institutional investors own 86.05% of the company's stock.

Universal Health Services Price Performance

Shares of NYSE UHS traded down $0.80 during mid-day trading on Thursday, reaching $165.10. The company's stock had a trading volume of 1,260,225 shares, compared to its average volume of 580,599. The stock has a 50-day moving average of $170.50 and a two-hundred day moving average of $153.01. The stock has a market capitalization of $11.10 billion, a P/E ratio of 15.93, a P/E/G ratio of 0.82 and a beta of 1.24. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.29 and a current ratio of 1.40. Universal Health Services, Inc. has a 1-year low of $119.90 and a 1-year high of $183.61.

Universal Health Services (NYSE:UHS - Get Free Report) last issued its earnings results on Wednesday, April 24th. The health services provider reported $3.70 EPS for the quarter, beating analysts' consensus estimates of $3.14 by $0.56. Universal Health Services had a net margin of 5.03% and a return on equity of 12.08%. The business had revenue of $3.84 billion during the quarter, compared to analysts' expectations of $3.78 billion. During the same period in the prior year, the business earned $2.34 earnings per share. The company's quarterly revenue was up 10.8% compared to the same quarter last year. On average, equities research analysts anticipate that Universal Health Services, Inc. will post 13.34 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Steve Filton sold 35,000 shares of the firm's stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $176.82, for a total value of $6,188,700.00. Following the completion of the transaction, the chief financial officer now owns 68,785 shares of the company's stock, valued at $12,162,563.70. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 16.10% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on UHS. Deutsche Bank Aktiengesellschaft reduced their target price on Universal Health Services from $208.00 to $203.00 and set a "buy" rating on the stock in a research note on Friday, April 12th. JPMorgan Chase & Co. raised their price target on Universal Health Services from $144.00 to $182.00 and gave the company a "neutral" rating in a report on Wednesday, March 13th. Stephens reaffirmed an "equal weight" rating and set a $185.00 price target on shares of Universal Health Services in a report on Thursday. Mizuho increased their price objective on shares of Universal Health Services from $175.00 to $200.00 and gave the company a "buy" rating in a research report on Wednesday, March 6th. Finally, TD Cowen increased their price objective on shares of Universal Health Services from $140.00 to $181.00 and gave the company a "market perform" rating in a research report on Friday, March 1st. One analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, Universal Health Services has a consensus rating of "Moderate Buy" and a consensus price target of $180.07.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.